Published in Artif Intell Med on March 27, 2010
Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays. Genome Biol (2008) 2.67
Characterization of the RNA content of chromatin. Genome Res (2010) 1.99
A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors. Clin Cancer Res (2012) 1.83
Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood (2009) 1.69
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer (2008) 1.66
Parallel gene analysis with allele-specific padlock probes and tag microarrays. Nucleic Acids Res (2003) 1.48
Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells. Nucleic Acids Res (2007) 1.36
Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene (2005) 1.33
Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue. Genome Biol (2013) 1.29
Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cells. Anticancer Drugs (2010) 1.25
Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity. Genome Biol (2011) 1.25
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica (2011) 1.25
Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23. Nephrol Dial Transplant (2007) 1.18
Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res (2003) 1.16
Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data. PLoS One (2009) 1.14
Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients. Biochem Pharmacol (2006) 1.12
Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res (2007) 1.11
STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer (2007) 1.09
Molecular markers for discrimination of benign and malignant follicular thyroid tumors. Tumour Biol (2006) 1.09
Bayesian detection of periodic mRNA time profiles without use of training examples. BMC Bioinformatics (2006) 1.05
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. Br J Cancer (2005) 1.05
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors. Haematologica (2010) 1.03
Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010. Clin Lab (2002) 1.01
Gene expression and muscle fiber function in a porcine ICU model. Physiol Genomics (2009) 0.95
Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer. J Thorac Oncol (2011) 0.94
Salivary cortisol and suicidal behavior--a follow-up study. Psychoneuroendocrinology (2008) 0.93
Screening of an annotated compound library for drug activity in a resistant myeloma cell line. Cancer Chemother Pharmacol (2006) 0.93
Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms. Clin Chem Lab Med (2004) 0.92
Prostasomal DNA characterization and transfer into human sperm. Mol Reprod Dev (2011) 0.91
Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia. Am J Hematol (2012) 0.91
Behavioural and Brain Gene Expression Profiling in Pigs during Tail Biting Outbreaks - Evidence of a Tail Biting Resistant Phenotype. PLoS One (2013) 0.91
Mechanisms underlying the sparing of masticatory versus limb muscle function in an experimental critical illness model. Physiol Genomics (2011) 0.89
Detection of phosphatidylethanol (PEth) in the blood of drivers in an alcohol ignition interlock program. Traffic Inj Prev (2011) 0.89
Improved variance estimation of classification performance via reduction of bias caused by small sample size. BMC Bioinformatics (2006) 0.88
The transcriptome of the adenovirus infected cell. Virology (2012) 0.87
CD99 is a novel prognostic stromal marker in non-small cell lung cancer. Int J Cancer (2012) 0.86
High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival. Genes Chromosomes Cancer (2011) 0.86
Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines. Cancer Chemother Pharmacol (2013) 0.85
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Haematologica (2010) 0.85
Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling. Anticancer Res (2010) 0.85
Exposure to CB-153 and p,p'-DDE and bone mineral density and bone metabolism markers in middle-aged and elderly men and women. Osteoporos Int (2005) 0.84
Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model. J Biomol Screen (2006) 0.84
Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles. Epigenetics (2012) 0.83
Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity. World J Surg (2003) 0.81
Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia. Am J Hematol (2012) 0.81
Revealing cell cycle control by combining model-based detection of periodic expression with novel cis-regulatory descriptors. BMC Syst Biol (2007) 0.81
Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area. Scand J Prim Health Care (2011) 0.81
External cross-validation for unbiased evaluation of protein family detectors: application to allergens. Proteins (2005) 0.81
Stathmin as a marker for malignancy in pheochromocytomas. Exp Clin Endocrinol Diabetes (2009) 0.81
High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden. Scand J Prim Health Care (2006) 0.80
Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease. BMC Cancer (2012) 0.80
Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients. Invest New Drugs (2008) 0.79
Lipoic acid increases glutathione production and enhances the effect of mercury in human cell lines. Toxicology (2002) 0.79
Folate deficiency is a common finding in psychogeriatric patients. Aging Clin Exp Res (2002) 0.79
Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas. Breast Cancer Res Treat (2008) 0.78
Shock-induced arrhythmogenesis in the human heart: A computational modelling study. Conf Proc IEEE Eng Med Biol Soc (2010) 0.78
Captopril suppression: limitations for confirmation of primary aldosteronism. J Renin Angiotensin Aldosterone Syst (2011) 0.77
Urticarial dermographism: clinical features and response to psychosocial stress. Acta Derm Venereol (2007) 0.77
Modeling the effect of Kv1.5 block on the canine action potential. Biophys J (2010) 0.77
Traces of copper ions deplete glutathione in human hepatoma cell cultures with low cysteine content. Chem Biol Interact (2007) 0.77
Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone. Scand J Clin Lab Invest (2009) 0.76
Decreased aldosterone in the plasma of suicide attempters with major depressive disorder. Psychiatry Res (2010) 0.75
Wrong biochemistry results. Information on incidents with consequences for health should be collected centrally. BMJ (2002) 0.75
Serum neuron specific enolase - impact of storage and measuring method. BMC Res Notes (2014) 0.75
In vitro drug sensitivity-gene expression correlations involve a tissue of origin dependency. J Chem Inf Model (2007) 0.75
Differentiation and quantification of synthetic phosphatidylethanol (PEth) homologues by ¹H- and ¹³C-NMR in polar organic solvents. Anal Bioanal Chem (2014) 0.75
[Regarding kidney function assessment (GFR) with formulas]. Lakartidningen (2008) 0.75
[Equalis/SFKK recommends harmonization of units in hormone determinations for safer care]. Lakartidningen (2012) 0.75
The polyphenol quercetin strongly increases homocysteine production in a human hepatoma (Hep G2) cell line. Clin Biochem (2005) 0.75
Gene expression analysis identifies a genetic signature potentially associated with response to alpha-IFN in chronic phase CML patients. Leuk Res (2007) 0.75
[Laboratory thyroid disease diagnosis--interdisciplinary cooperation. International consensus in Swedish perspective]. Lakartidningen (2005) 0.75
[Great number of non-recorded cases of analytical interference. Unexpected and misinterpreted laboratory levels can result in diagnostic and therapeutic errors]. Lakartidningen (2002) 0.75
[Optimal use of markers for cobalamin/folate status. Results from a survey in a group of psychogeriatric patients]. Lakartidningen (2003) 0.75